Roche personalized cancer treatment Rozlytrek priced at Rs 12 lakh per month Medical Dialogues Bureau17 Aug 2019 3:45 AM GMTRozlytrek was approved by the U.S. Food and Drug Administration on Thursday to treat certain types of solid tumours, which show rare genetic anomalies...